Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-27 @ 10:48 PM
Study NCT ID:
NCT01127633
Status:
TERMINATED
Last Update Posted:
2019-10-08
First Post:
2010-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-19
First Submit QC Date:
None
Study First Post Date:
2010-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-12
Results First Submit QC Date:
None
Results First Post Date:
2018-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-10-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-09-25
Last Update Post Date:
2019-10-08
Last Update Post Date Type:
ACTUAL